{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:42:31Z","timestamp":1775886151608,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013330","name":"Society of Cardiovascular Anesthesiologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007927","name":"The University of Oklahoma Health Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007927","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjanaesthesia.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["British Journal of Anaesthesia"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bja.2024.02.027","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T11:22:29Z","timestamp":1712575349000},"page":"1204-1210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in\u00a0vitro"],"prefix":"10.1016","volume":"132","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8467-8372","authenticated-orcid":false,"given":"Yuko","family":"Mishima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4802-4162","authenticated-orcid":false,"given":"Amir L.","family":"Butt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5631-949X","authenticated-orcid":false,"given":"Kofi B.","family":"Vandyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3766-4962","authenticated-orcid":false,"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9768-0417","authenticated-orcid":false,"given":"Kenneth E.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5051-1365","authenticated-orcid":false,"given":"Kenichi A.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bja.2024.02.027_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11239-021-02456-w","article-title":"Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics","volume":"52","author":"Camire","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.bja.2024.02.027_bib2","series-title":"Andexxa (coagulation factor Xa [recombinant], inactivated-zhzo) [package insert]","year":"2023"},{"key":"10.1016\/j.bja.2024.02.027_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1213\/XAA.0000000000001052","article-title":"Andexanet\u00a0alfa for urgent reversal of apixaban before aortic surgery requiring cardiopulmonary bypass: a case report","volume":"13","author":"Flaherty","year":"2019","journal-title":"A\u00a0A Pract"},{"key":"10.1016\/j.bja.2024.02.027_bib4","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/phar.2306","article-title":"Intraoperative unfractionated heparin unresponsiveness during endovascular repair of a ruptured abdominal aortic aneurysm following administration of andexanet\u00a0alfa for the reversal of rivaroxaban","volume":"39","author":"Eche","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bja.2024.02.027_bib5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/j.jvca.2020.10.042","article-title":"Successful antithrombin administration in andexanet\u00a0alfa-associated heparin resistance","volume":"35","author":"Apostel","year":"2021","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bja.2024.02.027_bib6","article-title":"Heparin insensitivity and thrombotic risk associated with sequential uses of prothrombin complex concentrate and andexanet\u00a0alfa for apixaban reversal during acute type a aortic dissection repair: a case report","volume":"16","author":"Brenner","year":"2022","journal-title":"A\u00a0A Pract"},{"key":"10.1016\/j.bja.2024.02.027_bib7","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1053\/j.jvca.2020.11.052","article-title":"Andexanet\u00a0alfa-induced heparin resistance: when anticoagulation really remains reversed","volume":"35","author":"Erdoes","year":"2021","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bja.2024.02.027_bib8","doi-asserted-by":"crossref","first-page":"33609","DOI":"10.1074\/jbc.M702462200","article-title":"Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin","volume":"282","author":"Izaguirre","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.bja.2024.02.027_bib9","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1182\/bloodadvances.2016003616","article-title":"Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors","volume":"2","author":"Kalathottukaren","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.bja.2024.02.027_bib10","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/bloodadvances.2017007112","article-title":"Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet\u00a0alfa","volume":"1","author":"Siegal","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.bja.2024.02.027_bib11","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMra2104091","article-title":"Heparin resistance - clinical perspectives and management strategies","volume":"385","author":"Levy","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bja.2024.02.027_bib12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00000542-200205000-00011","article-title":"Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study","volume":"96","author":"Levy","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bja.2024.02.027_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40981-023-00619-7","article-title":"Successful use of an antithrombin for heparin resistance with andexanet\u00a0alfa","volume":"9","author":"Honda","year":"2023","journal-title":"JA Clin Rep"},{"key":"10.1016\/j.bja.2024.02.027_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11239-019-01869-y","article-title":"Contradictory to its effects on thrombin, C1-inhibitor reduces plasmin generation in the presence of thrombomodulin","volume":"48","author":"Tarandovskiy","year":"2019","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.bja.2024.02.027_bib15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1538-7836.2004.00798.x","article-title":"Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time","volume":"2","author":"al Dieri","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.bja.2024.02.027_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.thromres.2019.02.013","article-title":"C1-esterase inhibitor enhances thrombin generation and spatial fibrin clot propagation in the presence of thrombomodulin","volume":"176","author":"Tarandovskiy","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.bja.2024.02.027_bib17","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0022-5223(94)70150-4","article-title":"Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations","volume":"108","author":"Despotis","year":"1994","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bja.2024.02.027_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1213\/ane.0b013e3181608f7c","article-title":"Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass","volume":"106","author":"Sniecinski","year":"2008","journal-title":"Anesth Analg"},{"issue":"Suppl 1","key":"10.1016\/j.bja.2024.02.027_bib19","first-page":"PB0306","article-title":"Reversal of heparin anticoagulation by andexanet\u00a0alfa (Andexanet) in human plasma and whole blood: differential effect of andexanet on antithrombin-dependent anticoagulants and direct thrombin inhibitors (DTIs) [abstract]","volume":"4","author":"Lu","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.bja.2024.02.027_bib20","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/j.1538-7836.2006.01896.x","article-title":"Disposition of tissue factor pathway inhibitor during cardiopulmonary bypass","volume":"4","author":"Donahue","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.bja.2024.02.027_bib21","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.3324\/haematol.2017.174037","article-title":"Catalytically inactive Gla-domainless factor Xa binds to TFPI and restores ex\u00a0vivo coagulation in hemophilia plasma","volume":"102","author":"Ersayin","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.bja.2024.02.027_bib22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.3102","article-title":"A\u00a0specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa","volume":"19","author":"Lu","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.bja.2024.02.027_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.thromres.2020.01.014","article-title":"Supplementation with antithrombin III ex\u00a0vivo optimizes enoxaparin responses in critically injured patients","volume":"187","author":"Cardenas","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.bja.2024.02.027_bib24","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1161\/01.CIR.93.11.2014","article-title":"Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass","volume":"93","author":"Chung","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.bja.2024.02.027_bib25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1067\/mtc.2002.120347","article-title":"Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits","volume":"123","author":"Aldea","year":"2002","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bja.2024.02.027_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0037-1613979","article-title":"Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass","volume":"84","author":"Philippou","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.bja.2024.02.027_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13019-015-0295-9","article-title":"Accelerated activation of the coagulation pathway during cardiopulmonary bypass in aortic replacement surgery: a prospective observational study","volume":"10","author":"Sato","year":"2015","journal-title":"J\u00a0Cardiothorac Surg"},{"key":"10.1016\/j.bja.2024.02.027_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jtcvs.2004.10.045","article-title":"Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass","volume":"130","author":"Avidan","year":"2005","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.bja.2024.02.027_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1053\/jcan.2003.42","article-title":"Management of heparin resistance during cardiopulmonary bypass: the effect of five different anticoagulation strategies on hemostatic activation","volume":"17","author":"Koster","year":"2003","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.bja.2024.02.027_bib30","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1213\/ANE.0000000000005721","article-title":"Survey of practice pattern in patients with heparin-induced thrombocytopenia requiring cardiopulmonary bypass","volume":"133","author":"Wanat-Hawthorne","year":"2021","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bja.2024.02.027_bib31","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1111\/bcp.15251","article-title":"Bivalirudin vs. heparin in paediatric and adult patients on extracorporeal membrane oxygenation: a meta-analysis","volume":"88","author":"Li","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bja.2024.02.027_bib32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jtcvs.2005.09.057","article-title":"A\u00a0comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study","volume":"131","author":"Dyke","year":"2006","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"Suppl 1","key":"10.1016\/j.bja.2024.02.027_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1182\/blood.V130.Suppl_1.629.629","article-title":"Effect of andexanet-TFPI interaction on in\u00a0vitro thrombin formation and coagulation markers in the TF-pathway","volume":"130","author":"Lu","year":"2017","journal-title":"Blood"}],"container-title":["British Journal of Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091224001260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007091224001260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:56:06Z","timestamp":1748739366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007091224001260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0007091224001260"],"URL":"https:\/\/doi.org\/10.1016\/j.bja.2024.02.027","relation":{},"ISSN":["0007-0912"],"issn-type":[{"value":"0007-0912","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombin supplementation attenuates heparin resistance in plasma spiked with Gla-domainless factor Xa S195A in\u00a0vitro","name":"articletitle","label":"Article Title"},{"value":"British Journal of Anaesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bja.2024.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 British Journal of Anaesthesia. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}